Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 337

1.

Resting-State Neurophysiological Activity Patterns in Young People with ASD, ADHD, and ASD + ADHD.

Shephard E, Tye C, Ashwood KL, Azadi B, Asherson P, Bolton PF, McLoughlin G.

J Autism Dev Disord. 2017 Sep 13. doi: 10.1007/s10803-017-3300-4. [Epub ahead of print]

PMID:
28900800
2.

Needs of Adolescents and Young Adults with Neurodevelopmental Disorders: Comparisons of Young People and Parent Perspectives.

Eklund H, Findon J, Cadman T, Hayward H, Murphy D, Asherson P, Glaser K, Xenitidis K.

J Autism Dev Disord. 2017 Sep 11. doi: 10.1007/s10803-017-3295-x. [Epub ahead of print]

PMID:
28894999
3.

Drug Treatments for ADHD Reduce Risk of Substance Use Disorders.

Asherson P.

Am J Psychiatry. 2017 Sep 1;174(9):827-828. doi: 10.1176/appi.ajp.2017.17070733. No abstract available.

PMID:
28859502
4.

Callous-unemotional traits moderate executive function in children with ASD and ADHD: A pilot event-related potential study.

Tye C, Bedford R, Asherson P, Ashwood KL, Azadi B, Bolton P, McLoughlin G.

Dev Cogn Neurosci. 2017 Aug;26:84-90. doi: 10.1016/j.dcn.2017.06.002. Epub 2017 Jun 13.

5.

Effects of stimulants and atomoxetine on emotional lability in adults: A systematic review and meta-analysis.

Moukhtarian TR, Cooper RE, Vassos E, Moran P, Asherson P.

Eur Psychiatry. 2017 Jul;44:198-207. doi: 10.1016/j.eurpsy.2017.05.021. Epub 2017 May 25.

PMID:
28646732
6.

Altered EEG spectral power during rest and cognitive performance: a comparison of preterm-born adolescents to adolescents with ADHD.

Rommel AS, James SN, McLoughlin G, Brandeis D, Banaschewski T, Asherson P, Kuntsi J.

Eur Child Adolesc Psychiatry. 2017 Jun 2. doi: 10.1007/s00787-017-1010-2. [Epub ahead of print]

7.

Cannabinoids in attention-deficit/hyperactivity disorder: A randomised-controlled trial.

Cooper RE, Williams E, Seegobin S, Tye C, Kuntsi J, Asherson P.

Eur Neuropsychopharmacol. 2017 Aug;27(8):795-808. doi: 10.1016/j.euroneuro.2017.05.005. Epub 2017 May 30.

PMID:
28576350
8.

Peripheral Hypoarousal but Not Preparation-Vigilance Impairment Endures in ADHD Remission.

James SN, Cheung CH, Rommel AS, McLoughlin G, Brandeis D, Banaschewski T, Asherson P, Kuntsi J.

J Atten Disord. 2017 Mar 1:1087054717698813. doi: 10.1177/1087054717698813. [Epub ahead of print]

PMID:
28363258
9.

Neurophysiological Correlates of Attentional Fluctuation in Attention-Deficit/Hyperactivity Disorder.

Cheung CHM, McLoughlin G, Brandeis D, Banaschewski T, Asherson P, Kuntsi J.

Brain Topogr. 2017 May;30(3):320-332. doi: 10.1007/s10548-017-0554-2. Epub 2017 Mar 14.

10.

The familial co-aggregation of ASD and ADHD: a register-based cohort study.

Ghirardi L, Brikell I, Kuja-Halkola R, Freitag CM, Franke B, Asherson P, Lichtenstein P, Larsson H.

Mol Psychiatry. 2017 Feb 28. doi: 10.1038/mp.2017.17. [Epub ahead of print]

PMID:
28242872
11.

Subcortical brain volume differences in participants with attention deficit hyperactivity disorder in children and adults: a cross-sectional mega-analysis.

Hoogman M, Bralten J, Hibar DP, Mennes M, Zwiers MP, Schweren LSJ, van Hulzen KJE, Medland SE, Shumskaya E, Jahanshad N, Zeeuw P, Szekely E, Sudre G, Wolfers T, Onnink AMH, Dammers JT, Mostert JC, Vives-Gilabert Y, Kohls G, Oberwelland E, Seitz J, Schulte-Rüther M, Ambrosino S, Doyle AE, Høvik MF, Dramsdahl M, Tamm L, van Erp TGM, Dale A, Schork A, Conzelmann A, Zierhut K, Baur R, McCarthy H, Yoncheva YN, Cubillo A, Chantiluke K, Mehta MA, Paloyelis Y, Hohmann S, Baumeister S, Bramati I, Mattos P, Tovar-Moll F, Douglas P, Banaschewski T, Brandeis D, Kuntsi J, Asherson P, Rubia K, Kelly C, Martino AD, Milham MP, Castellanos FX, Frodl T, Zentis M, Lesch KP, Reif A, Pauli P, Jernigan TL, Haavik J, Plessen KJ, Lundervold AJ, Hugdahl K, Seidman LJ, Biederman J, Rommelse N, Heslenfeld DJ, Hartman CA, Hoekstra PJ, Oosterlaan J, Polier GV, Konrad K, Vilarroya O, Ramos-Quiroga JA, Soliva JC, Durston S, Buitelaar JK, Faraone SV, Shaw P, Thompson PM, Franke B.

Lancet Psychiatry. 2017 Apr;4(4):310-319. doi: 10.1016/S2215-0366(17)30049-4. Epub 2017 Feb 16.

PMID:
28219628
12.

Comparative efficacy and tolerability of pharmacological interventions for attention-deficit/hyperactivity disorder in children, adolescents and adults: protocol for a systematic review and network meta-analysis.

Cortese S, Adamo N, Mohr-Jensen C, Hayes AJ, Bhatti S, Carucci S, Del Giovane C, Atkinson LZ, Banaschewski T, Simonoff E, Zuddas A, Barbui C, Purgato M, Steinhausen HC, Shokraneh F, Xia J, Cipriani A, Coghill D; European ADHD Guidelines Group (EAGG).

BMJ Open. 2017 Jan 10;7(1):e013967. doi: 10.1136/bmjopen-2016-013967.

13.

Glutamatergic and GABAergic gene sets in attention-deficit/hyperactivity disorder: association to overlapping traits in ADHD and autism.

Naaijen J, Bralten J, Poelmans G; IMAGE consortium, Glennon JC, Franke B, Buitelaar JK.

Transl Psychiatry. 2017 Jan 10;7(1):e999. doi: 10.1038/tp.2016.273.

14.

Association of Preterm Birth With Attention-Deficit/Hyperactivity Disorder-Like and Wider-Ranging Neurophysiological Impairments of Attention and Inhibition.

Rommel AS, James SN, McLoughlin G, Brandeis D, Banaschewski T, Asherson P, Kuntsi J.

J Am Acad Child Adolesc Psychiatry. 2017 Jan;56(1):40-50. doi: 10.1016/j.jaac.2016.10.006. Epub 2016 Oct 24.

15.

Genome-Wide Association of Heroin Dependence in Han Chinese.

Kalsi G, Euesden J, Coleman JR, Ducci F, Aliev F, Newhouse SJ, Liu X, Ma X, Wang Y, Collier DA, Asherson P, Li T, Breen G.

PLoS One. 2016 Dec 9;11(12):e0167388. doi: 10.1371/journal.pone.0167388. eCollection 2016.

16.

The European ADHD Guidelines Group replies.

Cortese S, Brandeis D, Holtmann M, Sonuga-Barke EJ; European ADHD Guidelines Group (EAGG).

J Am Acad Child Adolesc Psychiatry. 2016 Dec;55(12):1092-1093. doi: 10.1016/j.jaac.2016.09.492. No abstract available.

PMID:
27871646
17.

Modifiable Arousal in Attention-Deficit/Hyperactivity Disorder and Its Etiological Association With Fluctuating Reaction Times.

James SN, Cheung CH, Rijsdijk F, Asherson P, Kuntsi J.

Biol Psychiatry Cogn Neurosci Neuroimaging. 2016 Nov;1(6):539-547.

18.

Exome chip analyses in adult attention deficit hyperactivity disorder.

Zayats T, Jacobsen KK, Kleppe R, Jacob CP, Kittel-Schneider S, Ribasés M, Ramos-Quiroga JA, Richarte V, Casas M, Mota NR, Grevet EH, Klein M, Corominas J, Bralten J, Galesloot T, Vasquez AA, Herms S, Forstner AJ, Larsson H, Breen G, Asherson P, Gross-Lesch S, Lesch KP, Cichon S, Gabrielsen MB, Holmen OL, Bau CH, Buitelaar J, Kiemeney L, Faraone SV, Cormand B, Franke B, Reif A, Haavik J, Johansson S.

Transl Psychiatry. 2016 Oct 18;6(10):e923. doi: 10.1038/tp.2016.196.

19.

Family, twin, and adoption studies of childhood onset psychiatric and neurodevelopmental disorders.

Asherson P, Larsson H.

Am J Med Genet B Neuropsychiatr Genet. 2016 Oct;171(7):923-4. doi: 10.1002/ajmg.b.32474. No abstract available.

PMID:
27643501
20.

Attention-Deficit/Hyperactivity Disorder Remission Is Linked to Better Neurophysiological Error Detection and Attention-Vigilance Processes.

Michelini G, Kitsune GL, Cheung CH, Brandeis D, Banaschewski T, Asherson P, McLoughlin G, Kuntsi J.

Biol Psychiatry. 2016 Dec 15;80(12):923-932. doi: 10.1016/j.biopsych.2016.06.021. Epub 2016 Jul 5.

Supplemental Content

Loading ...
Support Center